Lab
Pearl Diagnostic Laboratory, LLC
Pearl Diagnostic Laboratory, LLC was paid $21K by Medicaid between Sep 2022 and Dec 2024, across 42 billing codes. Its largest line is 82306, Vitamin D; 25 hydroxy, includes fraction(s), if performed — 11% of everything it billed.
33Billing provider infoPEARL DIAGNOSTIC LABORATORY, LLC
LOUISVILLE, KY 40218
LOUISVILLE, KY 40218
33aNPI1215544549assigned 09/30/2020
33bProvider typeClinical Medical Laboratory
28Total paid$21K
24GClaims51,793
24DCodes billed42
24AFirst – last monthSep 2022 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Kentucky
Rank by total paid#42 of 73
Median peer was paid$95K
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 9,579 | $25.82 | |
| 2023 | 41,998 | $20K | |
| 2024incomplete | 216 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 11% | 834 | 700 | $2K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 11% | 8,039 | 4,452 | $2K |
| 80053 | Comprehensive metabolic panel | 11% | 4,873 | 3,453 | $2K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.1% | 5,415 | 3,444 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 7.1% | 3,678 | 2,097 | $2K |
| 80061 | Lipid panel | 6.9% | 1,571 | 1,286 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | 6.9% | 1,584 | 1,273 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | 5.4% | 1,807 | 1,371 | $1K |
| 85027 | 4.3% | 2,977 | 2,032 | $896.87 | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 3.5% | 55 | 37 | $732.40 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.9% | 160 | 111 | $618.26 |
| 80164 | 2.3% | 555 | 431 | $489.28 |
30 more codes
| 82607 | 2.0% | 597 | $417.21 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1.9% | 84 | $401.01 |
| 87077 | 1.6% | 697 | $341.99 | |
| 87186 | 1.6% | 559 | $331.63 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.5% | 1,063 | $320.28 |
| 80177 | 1.2% | 218 | $251.80 | |
| 82140 | 1.1% | 130 | $220.40 | |
| 83880 | 1.0% | 246 | $215.13 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 5,823 | $184.03 |
| 83735 | <1% | 425 | $181.68 | |
| 81001 | <1% | 1,348 | $167.69 | |
| 80076 | <1% | 185 | $156.22 | |
| 84439 | <1% | 341 | $148.91 | |
| 83550 | <1% | 205 | $128.12 | |
| 83540 | <1% | 285 | $118.99 | |
| 82746 | <1% | 264 | $116.40 | |
| 85610 | <1% | 951 | $106.25 | |
| 82728 | <1% | 124 | $73.80 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,657 | $37.35 |
| 86140 | <1% | 47 | $20.74 | |
| 84132 | <1% | 43 | $14.28 | |
| 84550 | <1% | 26 | $13.56 | |
| 80069 | <1% | 18 | $13.02 | |
| 84134 | <1% | 28 | $10.94 | |
| 80185 | <1% | 16 | $9.94 | |
| 83719 | 0% | 249 | $0.00 | |
| 87070 | 0% | 14 | $0.00 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 1,538 | $0.00 |
| 51701 | 0% | 43 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOMORUYI, OSAWARU (CEO)
| Provider | Location | Paid |
|---|---|---|
| Pearl Medical Practice PLLC | Louisville, KY | $4.29M |
| Pearl Geriatrics and Palliative Medicine, PSC | Louisville, KY | $809K |
| Medical Products Group, LLC | Wheaton, IL | $245K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.